Survival Rates for Thymus Cancer

Survival rates are a way for doctors to discuss the prognosis (outlook) for patients, based on the stage of the cancer or other traits. Learn more about survival rates for thymus cancer here.

Figure 4 looks at survival rates by the classification of the tumor. The rates drop mostly with B3, well-differentiated carcinoma, and then with thymic carcinoma.
Thymus Cancer Stage 4

The survival rate for stage 4 thymus cancer depends on how far the cancer has spread. Surgery might offer a cure if the cancer hasn't spread too far.
Prognosis estimates the outcome for thymus cancer . It depends on many factors including the classification and the stage.

Thymoma Survival Rate
The thymic cancer survival rate has been steadily improving as researchers have learned more about how the tumors respond to treatment. For instance, when a tumor can be surgically removed, the survival rates tend to be the most favorable. Even for advanced-stage thymomas that have traditionally been more difficult to treat, surgery performed in combination with radiation therapy and/or ...
Thymoma and thymic carcinoma treatment depends on the type, stage and cell characteristics. Learn about stages, treatments, prognosis and survival rate .

Survival Rate and Prognosis for Thymoma
According to data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program, the overall 5-year relative survival rate for thymoma is approximately 79-80%. This figure includes all stages and types of thymoma, providing a broad perspective on what is the outlook for thymoma.
Thymoma is a type of tumor that occurs in the thymus gland. Learn about the symptoms, causes, staging, treatment and survival rate of thymomas.

Thymoma and Thymic Carcinoma Treatment (PDQ)
Thymoma and thymic carcinoma treatment options include surgery, radiation therapy, chemotherapy, chemoradiation, and corticosteroids. Get detailed information about treatment of newly diagnosed and recurrent thymoma and thymic cancer in this summary for clinicians.



